跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Phyllanthus emblica extract
首页
药物
Phyllanthus emblica extract
Phyllanthus emblica extract
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cosmetic compositions
US 11185492 B2
申请人: MARY KAY INC
优先权: 2018
CN
US
4 件公开
MEDICINAL PLANT COMPOSITIONS / NUTRACEUTICAL FOR TREATING DIABETES PATIENTS
EP 4442267 A1
申请人: DIACURE GMBH
优先权: 2023
EP
WO
3 件公开
PHOTOPROTECTIVE COMPOSITION, USE THEREOF, AND SUNSCREEN COSMETIC
WO 2026108368 A1
申请人: YUNNAN BOTANEE BIO TECH GROUP CO LTD
优先权: 2024
CN
WO
2 件公开
Plant extracts composition for the treatment of liver dysfunction-jaundice
US 8431167 B2
申请人: SHUKLA MUKESH HARILAL
优先权: 2011
US
2 件公开
Application of phyllanthus emblica extract in preparation of pharmaceutical composition for improving mitochondrial activity in liver
CN 119185394 A
申请人: TAIWAN MITOCHONDRION APPLIED TECH CO LTD
优先权: 2017
CN
2 件公开
Compositions and methods for increase in muscle volume
US 10925911 B2
申请人: SUBSTRATE SOLUTIONS
优先权: 2020
US
2 件公开
ANTIVIRAL PLANT EXTRACT COMPOSITION AND METHOD FOR PREPARING SUCH COMPOSITION
EP 4205754 A1
申请人: CARIEL LEON
优先权: 2021
EP
2 件公开
PLANT EXTRACT COMPOSITION AND METHOD FOR PREPARING SUCH COMPOSITION
EP 4205751 A1
申请人: CARIEL LEON
优先权: 2021
EP
2 件公开
New use of iota-carrageenan, and emblic leafflower fruit composition
CN 116785444 A
申请人: UNIV CHENGDU TRADITIONAL CHINESE MEDICINE
优先权: 2023
CN
2 件公开
Nutritional composition for reducing blood fat and blood sugar and application thereof
CN 119909105 A
申请人: BIOSTIME GUANGZHOU HEALTH PRODUCT CO LTD
优先权: 2025
CN
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈